Exploring optimal sequencing of radiation and immunotherapy combinations

Area of Science:

• Oncology
• Immunology
• Radiation Oncology

Background:

• Combination treatments of radiation (RT) and immunotherapy are increasingly utilized in oncology.
• Determining the optimal sequence of RT and immunotherapy is critical for maximizing therapeutic efficacy.
• Limited data exists on the best sequencing strategies, particularly in clinical settings.

Purpose of the Study:

• To review and synthesize existing literature on the optimal sequencing of radiation and immunotherapy combinations.
• To provide a synopsis of historical and current research findings on this topic.

Main Methods:

• A comprehensive literature search was conducted using PubMed.
• Keywords included 'radiation', 'immunotherapy', and specific immune checkpoint inhibitors (e.g., PD1, PDL1, CTLA4), vaccines, and modulators (e.g., STING, TGFbeta).
• Studies focusing on the sequencing of RT and immunotherapy were selected and evaluated.

Main Results:

• A significant lack of primary literature directly investigating optimal sequencing exists, with most studies in the pre-clinical setting.
• The efficacy of combined RT and immunotherapy sequencing is dependent on the underlying mechanisms of action.
• Inhibiting immunosuppressive molecules before RT appears more effective, while engaging costimulatory pathways concurrently with RT shows promise.

Conclusions:

• Further basic research is urgently needed to investigate the efficacy of different sequencing strategies.
• Mechanisms of radiation-potentiated, immune-mediated cell death require deeper exploration.
• Understanding these mechanisms will guide the development of more effective combination cancer therapies.